TMPRSS2‐ERG fusion impacts anterior tumor location in men with prostate cancer.
- Published in:
- Prostate, 2021, v. 81, n. 2, p. 109, doi. 10.1002/pros.24086
- By:
- Publication type:
- Article
Works matching IS 02704137 AND DT 2021 AND VI 81 AND IP 2
Results: 8
1
2
Prostate specific membrane antigen (PSMA): A novel modulator of p38 for proliferation, migration, and survival in prostate cancer cells.
- Published in:
- Prostate, 2021, v. 81, n. 2, p. 142, doi. 10.1002/pros.24093
- By:
- Publication type:
- Article
3
CT‐based assessment of body composition following neoadjuvant chemohormonal therapy in patients with castration‐naïve oligometastatic prostate cancer.
- Published in:
- Prostate, 2021, v. 81, n. 2, p. 127, doi. 10.1002/pros.24088
- By:
- Publication type:
- Article
4
Spine metastasis in patients with prostate cancer: Survival prognosis assessment.
- Published in:
- Prostate, 2021, v. 81, n. 2, p. 91, doi. 10.1002/pros.24084
- By:
- Publication type:
- Article
5
The characteristics and spatial distributions of prostate cancer in autopsy specimens.
- Published in:
- Prostate, 2021, v. 81, n. 2, p. 135, doi. 10.1002/pros.24091
- By:
- Publication type:
- Article
6
Early‐onset prostate cancer is associated with increased risks of disease progression and cancer‐specific mortality.
- Published in:
- Prostate, 2021, v. 81, n. 2, p. 118, doi. 10.1002/pros.24087
- By:
- Publication type:
- Article
7
Influence of pelvic lymph node dissection and node‐positive disease on biochemical recurrence, secondary treatment, and survival after radical prostatectomy in men with prostate cancer.
- Published in:
- Prostate, 2021, v. 81, n. 2, p. 102, doi. 10.1002/pros.24085
- By:
- Publication type:
- Article
8
Issue Information.
- Published in:
- Prostate, 2021, v. 81, n. 2, p. 89, doi. 10.1002/pros.24000
- Publication type:
- Article